580 related articles for article (PubMed ID: 9614932)
1. Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69.
Gessl A; Waldhäusl W
Clin Immunol Immunopathol; 1998 May; 87(2):168-75. PubMed ID: 9614932
[TBL] [Abstract][Full Text] [Related]
2. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
Gessl A; Waldhäusl W
J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
[TBL] [Abstract][Full Text] [Related]
3. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases.
Bossowski A; Urban M; Stasiak-Barmuta A
J Pediatr Endocrinol Metab; 2003 Jan; 16(1):63-70. PubMed ID: 12585342
[TBL] [Abstract][Full Text] [Related]
4. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
5. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.
Corrales JJ; López A; Ciudad J; Mories MT; Miralles JM; Orfao A
J Endocrinol; 1997 Dec; 155(3):491-500. PubMed ID: 9487994
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric characterisation of the "false naive" (CD45RA+, CD45RO-, CD29 bright+) peripheral blood T-lymphocytes in health and in rheumatoid arthritis.
Neidhart M; Pataki F; Schönbächler J; Brühlmann P
Rheumatol Int; 1996; 16(2):77-87. PubMed ID: 8853229
[TBL] [Abstract][Full Text] [Related]
7. Circulating activated T cell subsets in autoimmune thyroid diseases: differences between untreated and treated patients.
Ohashi H; Okugawa T; Itoh M
Acta Endocrinol (Copenh); 1991 Nov; 125(5):502-9. PubMed ID: 1684685
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
9. Analysis of recently activated, memory and naive lymphocyte T subsets in the peripheral blood of patients with Graves' disease and insulin-dependent diabetes mellitus.
Kretowski A; Myśliwiec J; Turowski D; Wysocka J; Kinalska I
Rocz Akad Med Bialymst; 1999; 44():226-34. PubMed ID: 10697437
[TBL] [Abstract][Full Text] [Related]
10. Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease.
Ishikawa N; Eguchi K; Ueki Y; Nakashima M; Shimada H; Ito K; Nagataki S
Clin Exp Immunol; 1993 Nov; 94(2):363-70. PubMed ID: 7900942
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
Karlsson FA; Tötterman TH
Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
[TBL] [Abstract][Full Text] [Related]
12. Levels of regulatory T cells CD69(+)NKG2D(+)IL-10(+) are increased in patients with autoimmune thyroid disorders.
Rodríguez-Muñoz A; Vitales-Noyola M; Ramos-Levi A; Serrano-Somavilla A; González-Amaro R; Marazuela M
Endocrine; 2016 Mar; 51(3):478-89. PubMed ID: 26100786
[TBL] [Abstract][Full Text] [Related]
13. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
[TBL] [Abstract][Full Text] [Related]
14. Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.
Takenoyama M; Yasumoto K; Harada M; Matsuzaki G; Ishida T; Sugimachi K; Nomoto K
Immunobiology; 1996 Jul; 195(2):140-51. PubMed ID: 8877391
[TBL] [Abstract][Full Text] [Related]
15. Alterations in levels of CD28-/CD8+ suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients.
Crucian B; Dunne P; Friedman H; Ragsdale R; Pross S; Widen R
Clin Diagn Lab Immunol; 1995 Mar; 2(2):249-52. PubMed ID: 7697540
[TBL] [Abstract][Full Text] [Related]
16. Immunoregulatory molecules in patients with gestational diabetes mellitus.
Pendeloski KP; Mattar R; Torloni MR; Gomes CP; Alexandre SM; Daher S
Endocrine; 2015 Sep; 50(1):99-109. PubMed ID: 25754913
[TBL] [Abstract][Full Text] [Related]
17. Activated naive CD4+ peripheral blood T cells in autoimmune thyroid disease.
Gessl A; Wilfing A; Agis H; Steiner G; Czernin S; Boltz-Nitulescu G; Vierhapper H; Waldhäusl W
Thyroid; 1995 Apr; 5(2):117-25. PubMed ID: 7647571
[TBL] [Abstract][Full Text] [Related]
18. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
[TBL] [Abstract][Full Text] [Related]
19. Aberrant activation of CD8+ T-cell and CD8+ T-cell subsets in patients with newly diagnosed IDDM.
Hehmke B; Michaelis D; Gens E; Laube F; Kohnert KD
Diabetes; 1995 Dec; 44(12):1414-9. PubMed ID: 7589848
[TBL] [Abstract][Full Text] [Related]
20. Intrathyroidal accumulation of T cell phenotypes in autoimmune thyroid disease.
Martin A; Goldsmith NK; Friedman EW; Schwartz AE; Davies TF; Roman SH
Autoimmunity; 1990; 6(4):269-81. PubMed ID: 1716476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
